 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper128th MAINE LEGISLATURE
FIRST REGULAR SESSION-2017
Legislative Document No. 107
H.P. 75 House of  Representatives, January 17, 2017
An Act  To Increase the Effectiveness of Opioid Addiction Therapy
Reference to the Committee on Health  and Human Services suggested and  ordered printed.
ROBERT  B. HUNT
Clerk
Presented by Representative HYMANSON of York.
Cosponsored by Representatives:  BERRY of Bowdoinham, COREY  of Windham, 
GROHMAN of Biddeford, VACHON of  Scarborough, Senators: BREEN  of Cumberland, 
MIRAMANT of Knox, WOODSOME of York.

 
 Page 1 - 128LR0525(01) -1 
 Be it enacted by the People of the State of Maine as follows:  1 
Sec. 1.  22 MRSA §3174 -SS, as enacted by PL 2011, c. 477, Pt. I, §1, is repealed.  2 
Sec. 2.  22 MRSA §3174 -UU, sub -§7, ¶D, as amended by PL 2013, c. 368, Pt. 3 
AAAAA, §1, is further amended to read:  4 
D.  A MaineCare member for whom MaineCare reimbursement for opioid drugs for 5 
the treatment of addiction is restricted by limits applicable to methadone and a 6 
MaineCare member who is receiving  buprenorphine and naloxone combination drugs 7 
for the treatment of addiction ; and  8 
SUMMARY  9 
This bill repeals the 24 -month limit on MaineCare coverage or reimbursement for 10 
buprenorphine and naloxone combination drugs, also known as Suboxone, for the 11 
treatment of addiction to opioids.  12 
 
